We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$107M
1-Year Est. Return
82.62%
This Fund
S&P 500
This Quarter
Est. Return
+13.33%
1 Year Est. Return
+82.62%
3 Year Est. Return
+219.47%
5 Year Est. Return
+202.9%
10 Year Est. Return
–
AUM
$90.2M
AUM Growth
-$6.75M
(-7%)
Cap. Flow
-$13.9M
Cap. Flow
% of AUM
-15.42%
Top 10 Holdings %
Top 10 Hldgs %
39%
Holding
124
New
12
Increased
17
Reduced
57
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cencora
COR
|
+$926K |
| 2 |
Pentair
PNR
|
+$778K |
| 3 |
Plus Therapeutics
PSTV
|
+$606K |
| 4 |
Veritone
VERI
|
+$556K |
| 5 |
ZAGG
ZAGG Inc Common Stock (Delaware)
ZAGG
|
+$555K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$2.06M |
| 2 |
Tactile Systems Technology
TCMD
|
+$1.84M |
| 3 |
NeoGenomics
NEO
|
+$1.68M |
| 4 |
ATRS
Antares Pharma, Inc.
ATRS
|
+$1.68M |
| 5 |
Ooma
OOMA
|
+$1.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 60.72% |
| 2 | Industrials | 11.67% |
| 3 | Technology | 9.76% |
| 4 | Financials | 3.3% |
| 5 | Communication Services | 3.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Cencora
COR
$59.6B
| $983K | 1.09% |
+10,400
| New | +$926K |
|
27
H.B. Fuller
FUL
$3.01B
| $963K | 1.07% |
18,850
-950
| -5% | -$49K |
|
|
28
Plus Therapeutics
PSTV
$26.2M
| $962K | 1.07% |
5
+3
| +150% | +$606K |
|
29
Blackstone
BX
$151B
| $945K | 1.05% |
28,350
+12,200
| +76% | +$383K |
|
30
IRIDEX
IRIX
$16.1M
| $931K | 1.03% |
94,100
-5,900
| -6% | -$58.1K |
|
31
Stanley Black & Decker
SWK
$13.8B
| $922K | 1.02% |
6,550
-450
| -6% | -$61.7K |
|
32
Digital Turbine
APPS
$1.03B
| $889K | 0.99% |
863,580
-34,500
| -4% | -$36.5K |
|
33
Deluxe
DLX
$1.19B
| $858K | 0.95% |
12,400
-933
| -7% | -$65K |
|
|
INWK
34
DELISTED
InnerWorkings, Inc.
INWK
| $858K | 0.95% |
74,000
+34,000
| +85% | +$366K |
|
35
NCR Voyix
VYX
$1.13B
| $854K | 0.95% |
34,067
-2,690
| -7% | -$68.3K |
|
36
Vericel Corp
VCEL
$2.35B
| $850K | 0.94% |
257,600
+28,850
| +13% | +$79.1K |
|
|
FOCL
37
EDAP TMS S.A.
FOCL
$211M
| $844K | 0.94% |
255,800
-20,700
| -7% | -$58.9K |
|
|
ASRT
38
DELISTED
Assertio
ASRT
| $831K | 0.92% |
1,290
+29
| +2% | +$19.3K |
|
39
Expeditors International
EXPD
$23.5B
| $810K | 0.9% |
14,350
-950
| -6% | -$52.3K |
|
40
AngioDynamics
ANGO
$565M
| $805K | 0.89% |
49,650
-5,200
| -9% | -$82.2K |
|
|
41
Pentair
PNR
$10B
| $795K | 0.88% |
+17,794
| New | +$778K |
|
|
QUMU
42
DELISTED
Qumu Corp.
QUMU
| $787K | 0.87% |
269,634
-40,327
| -13% | -$113K |
|
43
ePlus
PLUS
$2.37B
| $741K | 0.82% |
20,000
| – | – |
|
|
SNAK
44
DELISTED
Inventure Foods, Inc.
SNAK
| $705K | 0.78% |
163,666
-7,000
| -4% | -$28.7K |
|
45
Donaldson
DCI
$10.5B
| $683K | 0.76% |
15,000
-600
| -4% | -$27.6K |
|
|
PFIE
46
DELISTED
Profire Energy, Inc
PFIE
| $683K | 0.76% |
525,606
| – | – |
|
47
Crane NXT
CXT
$2.94B
| $659K | 0.73% |
23,896
-1,151
| -5% | -$31.1K |
|
|
BBQ
48
DELISTED
BBQ Holdings, Inc. Common Stock
BBQ
| $634K | 0.7% |
176,100
+18,500
| +12% | +$72.2K |
|
|
ZAGG
49
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $602K | 0.67% |
+69,600
| New | +$555K |
|
50
Merck
MRK
$310B
| $590K | 0.65% |
9,642
+2,568
| +36% | +$156K |
|
Similar funds
EWL
ECM
HCA
CWM
SNPAM
TWM
ACL
FMI
Perkins Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Perkins Capital Management held 124 positions worth $90.2M, down 7% from $96.9M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Perkins Capital Management withdrew a net $13.9M in Q2 2017, closing 18 positions and reducing 57 holdings. Its most notable exit was Tactile Systems Technology, an estimated $1.84M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 61% of assets, up from 58% a quarter earlier, followed by Industrials and Technology.
Against the trend, Perkins Capital Management opened a new position in Cencora worth $983K.
- Perkins Capital Management's largest Q2 2017 buy was Cencora: 10,400 shares worth $983K.
- Perkins Capital Management added most to Plus Therapeutics in Q2 2017, an estimated $606K increase.
- Perkins Capital Management's biggest Q2 2017 reduction was Cardiovascular Systems, Inc., cutting an estimated $2.06M.
- Perkins Capital Management fully exited Tactile Systems Technology in Q2 2017, selling an estimated $1.84M.
- Perkins Capital Management's ten largest holdings make up 39% of its $90.2M portfolio in Q2 2017.
- Perkins Capital Management opened 12 new positions and closed 18 in Q2 2017.
- Perkins Capital Management's portfolio value fell 7% quarter-over-quarter to $90.2M.
Based on Perkins Capital Management's 13F filing for Q2 2017, filed 26 Jul 2017.